Gilles Besin

Company: Orbital Therapeutics

Job title: Chief Scientific Officer

Seminars:

Deep-Dive Workshop: Understanding Circular & Self-Amplifying RNAs Unique Potential as More Durable & Stable Therapeutics for Treating Patients in Need 9:00 am

Circular RNA and self-amplifying RNA have many differences to linear mRNA, they have greater stability and durability, however, it’s vital to understand how these properties can be taken advantage of for developing efficacious and safe therapeutics to treat a wide array of diseases which are currently undruggable. This session will deep dive into: Evaluating the…Read more

day: Conference Day One

Fireside Chat: Unlocking Priorities for the Next Generation RNA Community to Increase Investment for Driving More Therapeutics to the Patients in Need 2:00 pm

What are the current trends you have seen and identified within investment for circular and self-amplifying RNA therapeutics & vaccines? What innovations and priority actions need to take place to unleash the next frontiers in next generation RNA therapeutic development? What future opportunities and trends are you excited for in the circular and self-amplifying RNA…Read more

day: Conference Day One